glp-1 drugs for type 2 diabetes List of approved and pending medications GLP-1 Costs Explained: Managing Coverage

Published 2023 Feb 3

doi: 10.1371/journal.pone.0058784 [DOI] [PMC free article] [PubMed] [Google Scholar] 169

Mechanistic evidence has been mainly derived from short to medium term studies, evaluating the direct effects of GLP-1 RAs on coronary arteries immediately after administration or after a few weeks of treatment, whereas evidence on clinical events is mainly obtained from studies with up to several years of follow-up

Statements Author contributions AS: Conceptualization, Methodology, Resources, Writing original draft, Writing review & editing

Osteoarthritis pathogenesis: a review of molecular mechanisms

doi: 10.1038/oby.2007.204